Inhibition by Triptolide of IL-1-Induced Collagen Degradation by Corneal Fibroblasts

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 12, 2003, Pages 5082-5088

  Lu, Ying ^a   Fukuda, Ken ^a   Seki, Keisuke ^a   Nakamura, Yoshikuni ^a   Kumagai, Naoki ^a   Nishida, Teruo ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; GELATIN; GELATINASE A; GELATINASE B; HYDROXYPROLINE; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MESSENGER RNA; PLASMIN; RECOMBINANT ENZYME; STROMELYSIN; THIOL DERIVATIVE; THIOPEPTOLIDE; TRIPTOLIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; COLLAGEN DEGRADATION; CONTROLLED STUDY; CORNEA; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME PURIFICATION; ENZYME SUBSTRATE; FIBROBLAST; HYDROLYSIS; IMMUNOBLOTTING; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; ZYMOGRAPHY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; COLLAGEN; COLLAGENASES; CORNEA; DITERPENES; FIBROBLASTS; HYDROXYPROLINE; IMMUNOBLOTTING; INTERLEUKIN-1; MALE; PHENANTHRENES; PLASMIN; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIPTERYGIUM;

EID: 0345714658     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0476     Document Type: Article

References (38)

1. BenEzra D, Foidart JM. Collagens and non collagenous proteins in the human eye. I. Corneal stroma in vivo and keratocyte production in vitro. Curr Eye Res. 1981;1:101-110.
2. Fini ME, Girard MT, Matsubara M. Collagenolytic/gelatinolytic enzymes in corneal wound healing. Acta Ophthalmol Suppl. 1992;202:26-33.
3. Nishida T, Ueda A, Fukuda M, et al. Interactions of extracellular collagen and corneal fibroblasts: morphologic and biochemical changes of rabbit corneal cells cultured in a collagen matrix. In Vitro Cell Dev Biol. 1988;24:1009-1014.
4. Mishima H, Abe K, Otori T. Regulatory mechanism of procollagenase synthesis by keratocytes. In: J. Lass, ed. Advances in Corneal Research. New York: Plenum Press; 1997:413-420.
5. Ueda A, Nishida T, Otori T, Fujita H. Electron-microscopic studies on the presence of gap junctions between corneal fibroblasts in rabbits. Cell Tissue Res. 1987;249:473-475.
6. Hao JL, Nagano T, Nakamura M, et al. Galardin inhibits collagen degradation by rabbit keratocytes by inhibiting the activation of pro-matrix metalloproteinases. Exp Eye Res. 1999;68:565-572.
7. Nagano T, Hao JL, Nakamura M, et al. Stimulatory effect of pseudomonal elastase on collagen degradation by cultured keratocytes. Invest Ophthalmol Vis Sci. 2001;42:1247-1253.
8. Li Q, Fukuda K, Lu Y, et al. Enhancement by neutrophils of collagen degradation by corneal fibroblasts. J Leukocyte Biol. 2003;74:412-419.
9. Massova I, Kotra LP, Fridman R, Mobashery S. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J. 1998;12:1075-1095.
10. Gu WZ, Brandwein SR. Inhibition of type II collagen-induced arthritis in rats by triptolide. Int J Immunopharmacol. 1998;20:389-400.
11. Chang DM, Chang WY, Kuo SY, Chang ML. The effects of traditional antirheumatic herbal medicines on immune response cells. J Rheumatol. 1997;24:436-441.
12. Qiu D, Zhao G, Aoki Y, et al. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-κB transcriptional activation. J Biol Chem. 1999;274:13443-13450.
13. Zhao G, Vaszar LT, Qiu D, Shi L, Kao PN. Anti-inflammatory effects of triptolide in human bronchial epithelial cells. Am J Physiol. 2000;279:L958-L966.
14. Tao X, Schulze-Koops H, Ma L, et al. Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production. Arthritis Rheum. 1998;41:130-138.
15. Sylvester J, Liacini A, Li WQ, Dehnade F, Zafarullah M. Tripterygium wilfordii Hook F extract suppresses proinflammatory cytokine-induced expression of matrix metalloproteinase genes in articular chondrocytes by inhibiting activating protein-1 and nuclear factor-κB activities. Mol Pharmacol. 2001;59:1196-1205.
16. Lin N, Sato T, Ito A. Triptolide, a novel diterpenoid triepoxide from Tripterygium wilfordii Hook f, suppresses the production and gene expression of pro-matrix metalloproteinases 1 and 3 and augments those of tissue inhibitors of metalloproteinases 1 and 2 in human synovial fibroblasts. Arthritis Rheum. 2001;44:2193-2200.
17. Kumagai N, Fukuda K, Nishida T. Synergistic effect of TNF-α and IL-4 on the expression of thymus- and activation-regulated chemokine in human corneal fibroblasts. Biochem Biophys Res Commun. 2000;279:1-5.
18. Feldman LJ, Mazighi M, Scheuble A, et al. Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Circulation. 2001;103:3117-3122.
19. Sasaki K, Hattori T, Fujisawa T, et al. Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes. J Biochem (Tokyo). 1998;123:431-439.
20. Berman MB. Collagenase inhibitors: rationale for their use in treating corneal ulceration. Int Ophthalmol Clin. 1975;15:49-66.
21. Burns FR, Gray RD, Paterson CA. Inhibition of alkali-induced corneal ulceration and perforation by a thiol peptide. Invest Ophthalmol Vis Sci. 1990;31:107-114.
22. Schultz GS, Strelow S, Stern GA, et al. Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases. Invest Ophthalmol Vis Sci. 1992;33:3325-3331.
23. Berman MB. The role of α-macroglobulins in corneal ulceration. Prog Clin Biol Res. 1976;5:225-259.
24. Paterson CA, Wells JG, Koklitis PA, Higgs GA, Docherty AJ. Recombinant tissue inhibitor of metalloproteinases type 1 suppresses alkali-burn-induced corneal ulceration in rabbits. Invest Ophthalmol Vis Sci. 1994;35:677-684.
25. Fini ME, Girard MT. The pattern of metalloproteinase expression by corneal fibroblasts is altered by passage in cell culture. J Cell Sci. 1990;97:373-383.
26. Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJ. Stromelysin is an activator of procollagenase: a study with natural and recombinant enzymes. Biochem J. 1987;248:265-268.
27. Thakur A, Xue M, Stapleton F, et al. Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis. Infect Immun. 2002;70:2187-2197.
28. Fukuda M, Mishima H, Otori T. Detection of interleukin-1β in the tear fluid of patients with corneal disease with or without conjunctival involvement. Jpn J Ophthalmol. 1997;41:63-66.
29. Rudner XL, Kernacki KA, Barrett RP, Hazlett LD. Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates macrophage-inflammatory protein-2 production, polymorphonuclear neutrophil persistence, and corneal perforation. J Immunol. 2000;164:6576-6582.
30. Fini ME, Strissel KJ, Girard MT, Mays JW, Rinehart WB. Interleukin 1α mediates collagenase synthesis stimulated by phorbol 12-myristate 13-acetate. J Biol Chem. 1994;269:11291-11298.
31. West-Mays JA, Strissel KJ, Sadow PM, Fini ME. Competence for collagenase gene expression by tissue fibroblasts requires activation of an interleukin 1α autocrine loop. Proc Natl Acad Sci USA. 1995;92:6768-6772.
32. Kheradmand F, Werner E, Tremble P, Symons M, Werb Z. Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science. 1998;280:898-902.
33. Cook JR, Mody MK, Fini ME. Failure to activate transcription factor NF-κB in corneal stromal cells (keratocytes). Invest Ophthalmol Vis Sci. 1999;40:3122-3131.
34. Jiang XH, Wong BC, Lin MC, et al. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-κB activation in gastric cancer cells. Oncogene. 2001;20:8009-8018.
35. Berman M, Leary R, Gage J. Evidence for a role of the plasminogen activator-plasmin system in corneal ulceration. Invest Ophthalmol Vis Sci. 1980;19:1204-1221.
36. Tervo T, Salonen EM, Vahen A, et al. Elevation of tear fluid plasmin in corneal disease. Acta Ophthalmol (Copenh). 1988;66:393-399.
37. Thorig L, Wijngaards G, Van Haeringen NJ. Immunological characterization and possible origin of plasminogen activator in human tear fluid. Ophthalmic Res. 1983;15:268-276.
38. Riley GP, Harrall RL, Watson PG, Cawston TE, Hazleman BL. Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye. 1995;9:703-718.